NCT04594434

Brief Summary

This study wants to demonstrate the effectiveness of combining a positive memory with "recommended" therapy based on EMDR in reducing the disturbance that patients with complex psychotrauma may experience. The positive memory will be called "benevolent memory" (SB) or "less worse memory" (SMP).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 20, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

December 12, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 26, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2022

Completed
Last Updated

August 17, 2022

Status Verified

August 1, 2022

Enrollment Period

1.6 years

First QC Date

October 13, 2020

Last Update Submit

August 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of the combination of SB and / or PMS with EMDR technique on reducing the disturbance experienced by patients with complex psychotrauma.

    Percentage of patients with a 50% reduction in the SUD score(44/5000 measured by the SUD scale ranging from 0 to 10) at the end of the 3rd "active" EMDR session compared to the pre-treatment score of the 1st "active" session

    6 months

Secondary Outcomes (2)

  • Disturbance felt

    6 months

  • Level of dissociation

    6 months

Study Arms (2)

protocol EMDR + SB / SMP protocol (adjusted)

EXPERIMENTAL

Association of a positive memory with the "recommended" therapy based on EMDR.

Other: Scale SUDOther: VOC scaleOther: DES II scale

protocol EMDR (standard).

ACTIVE COMPARATOR

"recommended" therapy based on EMDR.

Other: Scale SUDOther: VOC scaleOther: DES II scale

Interventions

Subjective Units of Distress Scale ou Subjective Units of Disturbance Scale is a scale of subjective appreciation of emotions

protocol EMDR (standard).protocol EMDR + SB / SMP protocol (adjusted)

The VOC (Validity Of Cognition) scale is a scale of value given to cognition.

protocol EMDR (standard).protocol EMDR + SB / SMP protocol (adjusted)

The Dissociative Experiences Scale (DES), which is translated as the Dissociative Experiences Scale, is a self-questionnaire to assess the frequency of various dissociative symptoms in the patient's daily life.

protocol EMDR (standard).protocol EMDR + SB / SMP protocol (adjusted)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient suffering from a combination of a period of complex trauma and a disturbance triggered by situations in adulthood;
  • Having signed an informed consent form to participate in the study.

You may not qualify if:

  • Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
  • Patient seeking legal benefit from participating in the study;
  • Patient previously treated with EMDR;
  • Patient unable to understand the information related to the study (linguistic, psychological, cognitive reason, etc.);
  • Untreated epileptic patient;
  • Patient with severe oculomotor disorders;
  • Patient in hypomanic phase;
  • Patient treated with high dose corticosteroids;
  • Pregnant or likely to be (of childbearing age, without effective contraception) or breastfeeding;
  • Patient not beneficiary of a social security scheme.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique d'Yveline

Vieille-Église-en-Yvelines, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2020

First Posted

October 20, 2020

Study Start

December 12, 2020

Primary Completion

July 26, 2022

Study Completion

July 26, 2022

Last Updated

August 17, 2022

Record last verified: 2022-08

Locations